Dual Switch

K211605 · Laser Engineering, Inc. · GEX · Sep 22, 2022 · General, Plastic Surgery

Device Facts

• Record ID: K211605
• Device Name: Dual Switch
• Applicant: Laser Engineering, Inc.
• Product Code: GEX · General, Plastic Surgery
• Decision Date: Sep 22, 2022
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The intended use for the Aurora MD-30 CO2 Laser is for the vaporization, excision, ablation, or photocaogulation of soft tissue in the surgical specialties of ENT, Gynecology, Laparoscopic Surgery including GYN Laparoscopy, Aesthetic Surgery, Dental and Oral Surgery, Neurosurgery, Orthopedics, General Surgery and Podiatry.

Device Story

Aurora MD-30 CO2 Laser is a floor-standing surgical laser system; delivers up to 30W power at 11.2-micron infrared wavelength. System utilizes CO2 gas laser; operates in continuous, pulsed, or super-pulse modes. Integrated electromechanical linear motor controls optical switch; redirects beam between articulated arm and infrared fibers. User interface features 12-inch color touchscreen; visible aiming beam indicates delivery site. Operated by surgeons in clinical settings; provides precise soft tissue management. Output parameters controlled via console electronics. Benefits include versatile tissue interaction for various surgical specialties.

Clinical Evidence

Bench testing only. Compliance with IEC 60601-1 (General Safety), IEC 60601-1-6 (Usability), IEC 60601-2-22 (Laser Equipment), and IEC 60601-1-2 (EMC) demonstrated through successful performance testing.

Technological Characteristics

CO2 gas laser; 11.2-micron wavelength; 0.5-30W output power; TEM00 beam mode. Delivery via articulated arm or hollow waveguide. Electro-mechanical linear motor beam switching. 12-inch touchscreen control. Floor-standing console. Standards: IEC 60601-1, IEC 60601-1-6, IEC 60601-2-22, IEC 60601-1-2.

Indications for Use

Indicated for vaporization, excision, ablation, or photocoagulation of soft tissue in ENT, Gynecology, Laparoscopic Surgery (including GYN), Aesthetic Surgery, Dental/Oral Surgery, Neurosurgery, Orthopedics, General Surgery, and Podiatry.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• MD CO2 Surgical Laser System (K905676)
• Dual Switch (K951812)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in a larger, bold blue font. Below that is the word "ADMINISTRATION" in a smaller, bold blue font.

September 22, 2022

Laser Engineering, Inc. Laurie Dobbs Quality Assurance 475 Metroplex Drive Suite 401 Nashville, Tennessee 37211

Re: K211605

Trade/Device Name: Dual Switch Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: GEX Dated: May 20, 2021 Received: May 25, 2021

Dear Laurie Dobbs:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely.

Jianting Wang Acting Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K211605

Device Name Aurora MD-30 CO2 Laser

#### Indications for Use (Describe)

The intended use for the Aurora MD-30 CO2 Laser is for the vaporization, excision, ablation, or photocaogulation of soft tissue in the surgical specialties of ENT, Gynecology, Laparoscopic Surgery including GYN Laparoscopy, Aesthetic Surgery, Dental and Oral Surgery, Neurosurgery, Orthopedics, General Surgery and Podiatry.

Type of Use (Select one or both, as applicable)

| <span style="font-family: DejaVu Sans, sans-serif">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) |
|----------------------------------------------------------------------------------------------------------|
| <span style="font-family: DejaVu Sans, sans-serif">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Laser Engineering 510k

# 510(k) Summary

In accordance with 21 CFR 807.92 the 510(k) Summary for the Laser Engineering Aurora MD-30 CO2 Laser is provided below.

| Submitter: | Laser Engineering<br>475 Metroplex Drive, Suite 401<br>Nashville, TN 37211<br>Tel: [phone] |
|----------------------------|---------------------------------------------------------------------------------------------------|
| Contact Person: | Laurie Dobbs<br>Management Representative<br>Email: [e-mail] |
| Date Prepared: | 8-22-2022 |
| Device Proprietary Name: | Aurora MD-30 CO2 Laser |
| Device Common Name: | Aurora MD-30 CO2 Laser |
| Classification Name: | Powered Laser Surgical Instrument |
| Classification Regulation: | 21 CFR 878.4810 |
| Product Code: | GEX |
| Predicate Device Name(s): | MD CO2 Surgical Laser System<br>Dual Switch |
| Predicate Manufacturer: | Laser Engineering |
| Predicate 510k(s): | K905676, K951812 |

{4}------------------------------------------------

### Device Description:

The Aurora MD-30 CO2 Laser is a Carbon Dioxide (CO2) surgical laser system that can deliver up to 30 watts of laser power in the 11.2-micron range in the infrared. The laser can be used in a variety of surgical specialties. The power can be selectively delivered either through an articulated arm or through infrared fibers using an integrated electromechanically controlled optical switch that directs the beam either vertically into the articulated arm or at an angle into the fiber. The laser can operate in either continuous wave, pulsed or super pulse modes. It can deliver laser power down to 1/2 a watt and can operate down to millisecond pulse widths. The system also has a visible aiming beam to indicate where the CO2 laser beam will be delivered.

The laser system has a 12inch highly visible color touchscreen to control the laser. It consists of a small self-contained floor standing, easily moveable console which contains the laser and all associated electronics and delivery systems.

The Aurora MD-30 CO2 Laser has an integrated dual switch adapter that is operated by an electrical linear motor and controlled by the console. The switch allows the user to redirect the laser beam from the articulated arm to the fiber as desired.

### Indications for Use:

The intended use for the Aurora MD-30 CO2 Laser is for the vaporization, excision, ablation, or photocoagulation of soft tissue in the surgical specialties of ENT, Gynecology, Laparoscopic Surgery including GYN Laparoscopy, Aesthetic Surgery, Dental and Oral Surgery, Neurosurgery, Orthopedics, General Surgery and Podiatry.

### Technological Characteristics Compared to Predicate Device

| Product | Ultrapulse<br>Laser | MD CO2<br>Laser & Dual<br>Switch | Aurora MD-<br>30 CO2 laser | |
|--------------------------|----------------------|----------------------------------|------------------------------|---------|
| 510(K)<br>Number | K951812 | K905676 | K211605 | |
| Manufacturer | Coherent<br>/Lumenis | Laser<br>Engineering,<br>Inc | Laser<br>Engineering,<br>Inc | |
| Laser Type | CO2 Gas<br>Laser | CO2 Gas<br>Laser | CO2 Gas<br>Laser | Same |
| Operating<br>Wavelengths | 11.1<br>Microns | 10.6 Microns | 11.2 Microns | Similar |
| Output<br>Power | 0.5 to 45<br>Watts | 0.5 to 30<br>Watts | 0.5 to 30<br>Watts | Similar |
| Laser Beam<br>Mode | TEM00 | TEM00 | TEM00 | Same |

{5}------------------------------------------------

| Operating<br>Modes | Continuous<br>or Pulsed | Continuous<br>or Pulsed | Continuous<br>or Pulsed | Same |
|-----------------------------------|--------------------------------|----------------------------------------------|----------------------------------------------|--------------|
| Pulse Widths | 0.01 to 1.0<br>Sec | 0.05 to 1.0<br>Sec | 0.05 to 1.0<br>Sec | Same/Similar |
| Control<br>method | Computer<br>and<br>Touchscreen | Computer<br>and<br>Touchscreen | Computer<br>and<br>Touchscreen | Same |
| Aiming Beam<br>Power | 5 Milliwatts | 5 Milliwatts | 5 Milliwatts | Same |
| Laser Power<br>Delivery<br>System | Articulated<br>arm | Articulated<br>arm or<br>Hollow<br>Waveguide | Articulated<br>arm or<br>Hollow<br>Waveguide | Same/Similar |
| Beam<br>Switching<br>Method | n/a | Manual<br>Switch | Electro-<br>mechanical<br>Linear Motor | Different |
| Output<br>Indicator | LEDs | LEDs | LEDs | Same |

The proposed device's output parameters are either the same or similar as output parameters from the predicate devices. The proposed device uses an electro-mechanical motor rather than a manual switch to divert the output beam. This modification does not raise new types of questions regarding the safety and efficacy of the device, and the proposed device's beam diverter has been tested to demonstrate that it can be used safely and effectively for the proposed indications for use.

{6}------------------------------------------------

## Non-Clinical Testing Summary

| Test Standard | Test Description | Test Report | Test Results |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------|
| IEC 60601-1:2005<br>Ed.3+A1;C1:2014 | Medical Electrical Equipment - Part 1:<br>General Requirements For Basic<br>Safety And Essential Performance | 104954641BOX-<br>002 | PASS |
| IEC 60601-1-<br>6:2010Ed.3+A1 | Medical Electrical Equipment - Part 1-<br>6: General Requirements For Basic<br>Safety And Essential Performance -<br>Collateral Standard: Usability | 104954641BOX-<br>003 | PASS |
| IEC 60601-2-<br>22:2019 Ed.4 | Medical Electrical Equipment - Part 2-<br>22: Particular Requirements for Basic<br>Safety and Essential Performance of<br>Surgical, Cosmetic, Therapeutic and<br>Diagnostic Laser Equipment | 104954641BOX-<br>004 | PASS |
| IEC 60601-1-<br>2:2014Ed.4 | Medical Electrical Equipment - Part 1-<br>2: General Requirements For Safety -<br>Collateral Standard: Electromagnetic<br>Compatibility - Requirements And<br>Tests | 104954641BOX-<br>017 | PASS |

### Clinical Testing:

NA - Clinical testing was not required to establish substantial equivalence

### Conclusions:

The proposed device utilizes technological characteristics that are the same or are similar to the predicate devices. The proposed device's technological characteristics do not raise new types of questions regarding safety and effectiveness, and performance testing conducted supports that the device can be used safety and effectively for the proposed indications for use above. Based on the comparison and analysis of data within this 510(k) submission, the proposed device is considered to be Substantially Equivalent (SE) to the predicate devices.